ImmunologybioRxivPreprint
Distinct SARS-CoV-2 sensing pathways in pDCs driving TLR7-antiviral vs. TLR2-immunopathological responses in COVID-19
R. M. van der Sluis, L. B. Cham, A. G. Oliver…·M. R. Jakobsen
The paper shows that pDCs use TLR7 for antiviral responses and TLR2 for inflammatory responses to SARS-CoV-2, with neuropilin-1 inhibiting antiviral IFNs.
DOI 10.1101/2021.11.23.469755